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Abstract: The anxiolytic, hypnotic,  and anti-convulsant properties of benzodiazepines (BDZs)  require modulation of  
distinct GABAA receptor α-subtypes. BDZ modulation of GABAA receptors is often described in terms of increased open-
ing frequency, and contrasted with the increased open durations occurring with barbiturate modulation. Several studies 
spanning single channel, rapid kinetic, and whole cell techniques have suggested that BDZs effect this observed change  
in frequency through increased affinity for GABA. BDZ-sensitive αβγ isoforms exist at extrasynaptic as well as synaptic 
locations,  where  they  encounter  markedly  different  concentration  and  time-course  of  GABA  exposure.  Interestingly,  
this affinity-based mechanism (specifically, decreasing the GABA unbinding rate) is only predicted to increase opening 
frequency under conditions that allow the unbinding and rebinding cycles typical of prolonged exposure to low GABA 
concentrations, which are more likely to occur at extrasynaptic GABAA receptors. In contrast, when rebinding is less 
likely, such as may occur in certain synaptic conditions, the number, but not the frequency, of channel openings increases 
in response to BDZ modulation. In conclusion, not only can multiple kinetic mechanisms alter channel opening frequency, 
but a single mechanism – increased affinity – impacts opening frequency differently under different contexts of GABAA 
receptor activation. 
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INTRODUCTION 
  The therapeutic  importance of benzodiazepines (BDZs) 
spans multiple clinical domains, including seizures, anxiety, 
insomnia, and muscle relaxation. After studies of recombi-
nant receptors demonstrated that point mutations in α sub-
types effectively compromise BDZ modulation (α1(H101R), 
α2(H101R), α3(H126R),  and α5(H105R)), mice harboring 
these mutations (via knock-in) demonstrated that clinically 
relevant behavioral effects of BDZs were linked to GABAA 
receptors  containing  these  α  subtypes.  The  α1-containing 
receptors were linked to the sedative effects of BZDs [10, 
47], and behavioral and EEG characteristics of sleep were 
insensitive to diazepam in these transgenic mice [52]. The 
new-generation BDZ site hypnotics (zolpidem, zaleplon, and 
eszopiclone)  are  relatively  α1  selective,  although  pharma-
cokinetic benefits over classical BDZ ligands may also con-
tribute to their improved therapeutic utility [12]. The α2 sub-
type has been associated with the anxiolytic effects of BZDs 
[29]. Despite provocative localization of α3 subtype in the 
thalamic  reticular  nucleus,  the  sedative  and  sleep-EEG  ef-
fects of BDZs were intact in the α3 knock-in mice [24]. Tol-
erance to the sedating effects of BDZ (but not the sedation 
itself) was shown to depend on the α5 subtype [54]. Some 
overlap in functional roles among the α subtypes is likely, 
given findings such  as the abolished sleep EEG  effects of 
BDZs in the α2 knock-in [25], and the partial compromise of 
anticonvulsant  activity  of  the  α1  knock-in.  Also,  these 
knock-in mutations may affect baseline neurophysiology, as  
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increased  behavioral  excitability  in  the  α2  knock-in  mice 
was  reported  [37].  Another  possible  concern  involves  the 
potential disruption of signaling by endogenous  BDZs,  al-
though this topic remains controversial [9]. Although a hu-
man epilepsy mutation reported to abolish BDZ activity was 
supportive  of  an  endozepine  mechanism,  BDZ  sensitivity 
was subsequently confirmed [3].  
BDZ  MODULATION  OF  GABAA  RECEPTOR  
AFFINITY  
  Early work at the whole cell  [7, 30] and single channel 
[46, 53] levels confirmed GABAA receptors as the BDZ tar-
gets. Single GABAA receptors from dorsal root ganglia dem-
onstrated increased single-channel opening frequency in re-
sponse to the BDZ diazepam, without any change in mean 
open duration. The increase in single channel frequency seen 
with BDZs is often contrasted with the effect of barbiturates: 
increased open duration without altering opening frequency 
[31, 50, 53]. The proposed mechanism behind  this kinetic 
observation  involved  increased  affinity  of  GABA  for  the 
receptor [46]. Subsequent whole cell data demonstrated an 
isolated left-shift in the GABA concentration-response curve 
without affecting the macroscopic current shape (within the 
limitations of slow oocyte perfusion) [15]. Although binding 
studies have also consistently shown that BDZs increase the 
affinity for GABA, the measurement of binding affinity can 
be contaminated by effects on gating [8].  
  One implication of an affinity-based mechanism is that 
the  observed  functional  effects  of  BDZ  modulation  could 
depend upon the GABA concentration. Modulating affinity 
is predicted, for example, to have markedly different impact 
on peak current amplitude measurements, depending on the 
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most easily appreciated when considering a modulator caus-
ing  a  left-shift  in  the  sigmoidal  GABA  concentration  re-
sponse  curve:  the  enhanced  current  amplitude  would  be 
greater when tested at EC30 than EC90 GABA concentrations. 
The  experimental  conditions  of  the  single  channel  studies 
involved prolonged exposure to low GABA concentrations 
that resembled those occurring in extrasynaptic or tonic sig-
naling in vivo (persistent ~1 µM GABA exposure) [13, 16, 
26, 49, 55]. Synaptic exposure to GABA, in contrast, differs 
in the duration (transient) and concentration (high) of GABA 
encountered  during  these  phasic  events  [21].  How  would 
GABAA receptor single channel kinetics change in response 
to  increased  affinity  under  synaptic  versus  extrasynaptic 
conditions?  
PREDICTED  IMPACT  OF  CHANGING  GABA  
AFFINITY  UPON  GABAA  RECEPTOR  MACRO-
SCOPIC CURRENT PROPERTIES. 
  The microscopic affinity of an agonist refers to the ratio 
of the binding to the unbinding rate constants, whereas affin-
ity attributed to the EC50 of the concentration response curve 
or  of  binding  studies  is  influenced  by  gating  as  well  [8]. 
Whether modulating  affinity  involves kon or koff, a  strictly 
affinity-based mechanism of modulation predicts that BDZs 
will  increase  peak  current  amplitude  only  if  receptors  are 
activated  by  sub-saturating  GABA  concentrations.  Once 
exposed to saturating agonist concentrations, the current am-
plitude ceiling would not be further increased by increasing 
GABA  affinity.  For  similar  reasons,  macroscopic  current 
desensitization observed during continued exposure to satu-
rating  GABA  concentrations  should  not  be  altered  by  in-
creasing GABA affinity [4]. The ceiling effect in both cases 
simply reflects the asymptotic approach to a fully liganded 
state of the receptors. 
  Experimental and simulation work has demonstrated that 
the  current  relaxation  after  GABA  washout  (deactivation) 
depends  on  multiple  factors.  Unlike  peak  amplitude  and 
macroscopic  desensitization,  deactivation  is  sensitive  to 
changes in affinity even when receptors are stimulated with 
saturating GABA. For brief saturating GABA exposure with 
instant washout (square pulse), deactivation should be sensi-
tive  to  changes  in  GABA  affinity  only  if  they  involve 
changes in the unbinding rate constant. Modulating the ago-
nist binding rate constant could contribute to deactivation at 
synapses under conditions of sub-saturating GABA concen-
tration or slow  clearance of free GABA after synaptic re-
lease. However, if one assumes that there is negligible op-
portunity  for  rebinding  of  free  GABA  after  the  transient 
pulse, the predicted roles of kon and koff are straightforward 
and will be explored below. In concentration jump experi-
ments using small cells lifted from the recording dish, rapid 
washout of free GABA is a reasonable assumption [1] (see 
below).  
  Simplified models have proven useful for investigating 
the relationship between microscopic and macroscopic cur-
rent kinetics [2, 4, 38]. Only 4 states are considered in this 
model: a resting closed state (closed-unbound, Cu), a GABA-
bound closed state (closed-bound, Cb) accessed by a single 
GABA binding step, a GABA-bound open state (open, O), 
and  an  additional  GABA-bound  closed  state  (desensitized, 
D) (Fig. 1A). The D state permits macroscopic desensitiza-
tion to occur, depending on the GABA concentration and the 
relative rate constants associated with O and D [4, 38]. When 
simulated  currents were  evoked by saturating GABA con-
centrations, neither the peak amplitude, nor the macroscopic 
desensitization time-course was affected by increased affin-
ity, whether achieved by increasing kon (not shown) or by 
decreasing koff (Fig. 1C) [5]. The range of koff variation dis-
cussed in these simulations were chosen to reflect the typical 
~50% or greater slowing of the decay kinetics of deactiva-
tion [39, 5, 44], and are not meant to represent true GABA 
unbinding rate constants in recombinant or native receptors 
(Haas et al. [17] modeled koff as 170/s). This result is ex-
pected since the gating portion of the model, which dictates 
the amplitude and desensitization time course, is insensitive 
to the binding step provided that saturating GABA is present. 
Decreasing  koff  did  prolong  deactivation,  as  expected, 
whereas increasing kon had no effect [5]. Thus, affinity-based 
prolongation  of  deactivation  is  restricted  to  the  unbinding 
rate constant koff. This pattern holds for more comprehensive 
models  provided  that  unbinding  remains  a  terminal  event 
[17, 27]. 
  Single channel simulations offered an opportunity to de-
termine  how  changes  in  affinity  are  predicted  to  impact 
opening frequency under synaptic and extrasynaptic condi-
tions  [5].  For  the  purposes  of  this  analysis,  opening  fre-
quency is defined operationally as the number of observed 
openings per unit time. Although some authorities refer to 
the  inverse  of  brief  closed  duration(s)  as  the  opening  fre-
quency, an alternative interpretation of brief (intraburst) clo-
sures is that they represent “distal” closed states. Work from 
the  Macdonald  laboratory  has  modeled  3  distinct  opening 
rate  constants  per  open  state:  one  “standard”  opening  rate 
constant  and  two  opening  rate  constants  from  the  distal 
closed states [17]. Here, because the generic model used in 
the simulations has only one open state, and one rate con-
stant leading to it, the distinction is not relevant. However, as 
we will see below, even in such a simple model, the opening 
rate constant is not equivalent to the opening frequency. 
  The simple kinetic model in Fig. (1A) is representative of 
a more general class of models with two important features: 
1) unliganded receptors can only access “gating states” after 
ligand  binds,  and  2)  once  bound,  receptors  cannot  unbind 
GABA  while  they  are  visiting  gating  states  (in  this  case, 
states O and D). The first feature does not allow for sponta-
neous (unliganded) openings. Although such events clearly 
occur in certain circumstances, such as mutations or when an 
epsilon subunit is present [40, 48], they are low probability 
events in α1β3γ2L isoforms. The second feature also implies 
that unliganded gating does not occur, but refers specifically 
to gating in receptors that were already activated by and sub-
sequently released GABA. In other words, in this class of 
models,  because  a  receptor  cannot  continue  gating  after 
GABA has unbound, unbinding is  considered  the  terminal 
event in the deactivation process. This latter feature has im-
portant implications for the simulations that follow.  
  Although models containing “cyclic” features (in which 
agonist can bind to and unbind from any state) have been 
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isoform, all open and pre-open states must be GABA bound 
[1]. This conclusion was based on experimental demonstra-
tion  that  deactivation  currents  following  GABA  exposure 
were resistant to bicuculline block. Considerable opportunity 
for GABA rebinding exists during GABA washout, if cells 
are recorded while adherent to the culture dish, even in con-
centration  jump  experiments.  This  is  shown  in  Fig.  (1B), 
which compares the deactivation currents in three conditions: 
adherent cell, control wash; adherent cell, bicuculline wash, 
and lifted cell, control wash. The inverse agonist bicuculline 
antagonizes open channels only when GABA is not bound 
(such as  mutation-induced spontaneous openings, or direct 
activation  with  other  agents  such  as  neurosteroids).  When 
rebinding opportunity is minimized by lifting the cell, bicu-
culline  antagonism  of  deactivation  currents  is  also  mini-
mized.  This  finding  also  indicates  that  the  contribution  of 
unliganded channels (those that have unbound GABA) to the 
openings that constitute deactivation currents can be taken as 
negligible,  and  unbinding  can  be  considered  as  a  terminal 
event in the kinetic scheme as described above.  
  A  complementary  experimental  argument  against  kon 
modulation  underlying  a  BDZ-induced  change  in  GABA 
affinity  involved  similar  double  jump  experiments  as  de-
scribed above with bicuculline. Demonstrating enhancement 
of  current  deactivation  by  a  modulator  applied  selectively 
during GABAA receptor deactivation – that is, with GABA 
bound and channels visiting gating states, but in the absence 
of free GABA, precludes an effect on kon [1]. In those ex-
periments, diazepam delivered selectively during the deacti-
vation process enhanced the current, consistent with an effect 
on koff but incompatible with an effect on kon.  
SINGLE CHANNEL SIMULATIONS UNDER EXTRA-
SYNAPTIC CONDITIONS. 
  The majority of extrasynaptic GABAA receptors contain 
the δ subunit, which renders them insensitive to BDZs [33, 
34].  However,  receptors  containing  a  γ  subunit  are  some-
times targeted to non-synaptic membranes in regions such as 
the hippocampus [16]. Thus it is important to consider how 
BDZ modulation of GABAA receptor channels might mani-
fest under extrasynaptic conditions, which may serve impor-
tant physiological roles [26, 42, 49]. Single channel simula-
tions  using  the  simple  model  above  allowed  unambiguous 
determination of the occupation of different types of closed 
states by assigning artificial conductance levels (Fig. 2A). In 
actual  single  channel  experiments,  multiple  kinetic  states 
with the same conductance (and therefore indistinguishable 
by amplitude  criteria)  can be resolved statistically through 
analysis of the duration histogram of many events. However, 
the question we wanted to answer required kinetic informa-
tion  available  only  in  silico:  the  exact  moment  of  GABA 
unbinding.  Here,  the  imposed  conductance  levels  allowed 
distinction  between  occupancy  of  the  unbound  state  (Cu, 
level 1) versus the GABA-bound non-conducting states (Cb 
and D, level 2) and conducting state (O, level 3). This strat-
egy overcomes a critical limitation for testing the above hy-
pothesis for an affinity-based BDZ mechanism: one cannot 
experimentally measure the exact time of agonist dissocia-
tion  from  a  single  channel,  which  is  required  to  calculate  
the  opening  frequency  under  synaptic  conditions.  In  other 
words,  one  would  not  know  when  to  “stop  looking”  
after delivering a brief  GABA pulse,  in order  to calculate 
openings-per-time.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). GABAA receptor model and macroscopic currents. (A). 4-
state kinetic model containing a single resting unbound closed state 
(Cu), a bound closed state (Cb),and one open (O) and one desensi-
tized (D) state. Rate constants have units of s
-1, except kon, which is 
in units of M
-1s
-1, as follows: kon = 5 x 10
6; koff = 1000; kopen = 800; 
kclose = 500; kdesens = 800; kresens = 100. (B). Experimental traces 
from α1β3γ2L receptors in a single whole cell patch clamp experi-
ment. Only the terminal portion of each trace is shown (a 400 ms 
concentration jump in 1 mM GABA preceded the washout). Solid 
line, deactivation while cell remains adherent to the recording dish; 
note the slow time course reflecting GABA rebinding due to impre-
cise washout. Dashed line, deactivation while cell remains adher-
ent,  but  had  been  jumped  from  GABA  into  bicuculline  (1  µM), 
instead of control wash; note the sharper deactivation. Gray line, 
deactivation after cell was lifted from the recording dish, improving 
solution exchange (control wash); note the similarity with the bicu-
culline wash, as lifting the cell or exposing the intact cell to bicu-
culline  similarly  prevented  GABA  rebinding.  (C).  Increasing 
GABA  affinity  by  decreasing  koff  prolongs  deactivation  without 
altering the current shape during the GABA pulse (peak amplitude, 
desensitization). The asterisk indicates baseline parameters; slower 
deactivation occurred when koff was decreased to 200 and 50 s
-1. 
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  By decreasing koff, BDZs would decrease the likelihood 
of a channel entering the unbound state Cu, which is long-
lived at low GABA concentration. This would result in de-
creased average closed time, which would indirectly increase 
opening  frequency.  Simulations  confirmed  this  prediction 
when  frequency  was  measured  across  a  range  of  affinity 
(koff) parameters (Fig. 2B). However, if the analysis of open-
ings is restricted to the time when the channel was GABA-
bound (which cannot be done experimentally), opening fre-
quency was not increased as affinity was changed (Fig. 2C). 
This result confirms that the change in frequency seen in Fig. 
(2B) derives from the decrease in time spent in the unbound 
state. The small trend toward decreased frequency may relate 
to the fact that decreasing koff increases the lifetime of Cb, 
which  contributes  to  the  GABA-bound  closed  time,  and 
therefore impacts calculations of opening frequency (how-
ever this change is small relative to the overall bound-closed 
time which is dominated by the D state).  
SINGLE CHANNEL SIMULATIONS UNDER SYNAP-
TIC CONDITIONS 
  Consider the extreme case of synaptic GABA release that 
rapidly reaches peak concentration and then rapidly falls to 
zero concentration (a square pulse). Even if receptors are not 
saturated, if GABA is immediately cleared from the synaptic 
cleft, no rebinding can occur and the post-synaptic current 
time-course  will  reflect  transitions  among  GABA-bound 
states. In this case, the context resembles the above analysis 
in  which  frequency  calculations  were  restricted  to  times 
when GABA was bound – which predicts no change in fre-
quency  under  synaptic  conditions.  Simulated  brief  (1  ms) 
square  pulses  of  high  GABA  concentration,  mimicking  
phasic synaptic events, confirmed this prediction (Fig. 3) [5]. 
The  opening  frequency  was  not  increased  by  simulating 
BDZ modulation acting to slow the unbinding rate constant 
(Fig. 3B). However, as expected, slower unbinding increased 
the total number of openings (Fig. 3C), simply by virtue of 
additional  time  to  access  bound  states  before  the  terminal 
unbinding event occurred.  
  Although  the  precise  time-course  of  GABA  clearance 
may  be  variable  under  synaptic  conditions,  the  slowed 
GABA unbinding that increases the number of openings may 
be the dominant mechanism of BDZ-mediated prolongation 
of synaptic currents. Exceptions to this type of “saturating 
square pulse” synaptic simulation certainly exist, either be-
cause peak concentrations are not saturating, or because of 
slow re-uptake or spillover that allow sub-saturating concen-
trations to linger in the cleft [44, 45]. Although the conclu-
sions are unchanged by non-saturating pulses, under circum-
stances of lingering free GABA, a mixture of increased fre-
quency and increased number of openings can be expected, 
in proportion to the relative opportunities for rebinding be-
fore GABA is finally cleared. Also, the precise concentration 
of neurotransmitter remaining in the synaptic cleft between 
vesicular release events is uncertain. This potential residual 
cleft concentration may be regulated by different factors than 
those controlling extrasynaptic concentrations, as well as the 
equilibrium between the cleft compartment and neighboring 
extrasynaptic  space.  The  precise  concentration  profile  of 
GABA at central synapses remains uncertain [16, 18, 21, 36, 
41, 43, 44]. Nevertheless, the central conclusion is that the 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Simulated single channels under extrasynaptic conditions. (A). Single channels were simulated such that unbound closed (Cu), 
bound closed (Cb and D), and bound open (O) states are distinguished via different conductance levels (levels 1, 2 and 3, respectively) (QUB 
software, www.qub.buffalo.edu). Notice the increased time spent in bound states when koff is decreased (lower panel). Repeated 2 second 
exposures to 1 µM GABA were used to generate the data summarized in panels B and C. The Markov states corresponding to the conduc-
tance levels (1-3) are also shown on the right of traces in panel A and B. (B). Overall opening frequency increased as affinity was increased 
(via decreasing koff). (C). When frequency analysis is restricted to times when GABA is bound, it is unchanged by decreasing koff. Adapted 
from reference [5] with permission. 14    Current Neuropharmacology, 2010, Vol. 8, No. 1  Matt T. Bianchi 
manifestation  of  changing  affinity  upon  measurement  of 
opening frequency is critically dependent upon the extent to 
which unbinding and rebinding of GABA can occur. When 
rebinding can occur, the opening frequency increases as af-
finity  increases,  but  when  it  cannot  occur,  the  increase  in 
affinity  leads  to an increased number of openings without 
increasing their frequency.  
GABAA RECEPTOR DEACTIVATION DEPENDS ON 
MULTIPLE FACTORS. 
  The  simulations  demonstrate  that  BDZs  extend  the  
opportunity  for  individual  receptors  to  transition  among 
GABA-bound states, leading to prolonged deactivation after 
brief (synaptic) pulses by increasing the number of openings. 
Unlike desensitized states, which can also prolong deactiva-
tion  by  increasing  the  average  time  receptors  are  GABA-
bound  [4,  20],  decreasing  koff  will  necessarily  increase 
charge  transfer.  Increasing  stability  of  desensitized  states 
will accelerate early deactivation, and prolong the slow por-
tions of deactivation.  
  For non-cyclic models such as Fig. (1A), deactivation is 
predicted to be sensitive  to changes in every rate constant 
except kon (except theoretically when changes in kon render a 
given GABA concentration likely to produce predominantly 
mono-liganded receptors, which may have access to distinct 
gating states in 2-binding site models). Although changes in 
open and desensitized states fundamentally change the shape 
of deactivation, the effects of modulating koff appear to pro-
vide a mechanism to slow the rate of deactivation up to a 
boundary  defined  by  the  macroscopic  desensitization  time 
course [4]. The macroscopic desensitization time-course with 
prolonged saturating GABA exposure defines this limit such 
that, for a simulated synaptic pulse when koff = zero (infinite 
affinity), the current does not exceed the macroscopic desen-
sitization  time-course  (Fig.  4).  Increasing  the  stability  of 
open states will also prolong deactivation, with concomitant 
effects  on  macroscopic  desensitization  (and  therefore  the 
deactivation  boundary  for  affinity  related  changes)  [2,  4]. 
Likewise, changing the stability of desensitized states alters 
deactivation, as well as macroscopic desensitization. How-
ever, for any given set of open and desensitized stability pa-
rameters, the enhancement of deactivation from changes in 
koff will be limited by the macroscopic time course of desen-
sitization.  
 
 
 
 
 
 
 
 
Fig. (4). Macroscopic desensitization sets the limit of koff-mediated 
slowing  of  deactivation.  Simulated  macroscopic  currents  (solid 
lines) evoked by 1 ms pulses of 1 mM GABA, across a range of koff 
values (200, 100, 30, 10, and 0). koff = 200 is indicated by the solid 
circle, while koff = 0 is indicated by the open circle. A typical BZD-
induced prolongation is represented by the koff value of 100 (adja-
cent to koff = 200, indicated by the solid circle). These are shown in 
comparison with a 200 ms pulse of 1 mM GABA (gray line). No-
tice that the progressive slowing of deactivation following the brief 
pulses approaches a limit set by the macroscopic shape of the cur-
rent during prolonged exposure. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Simulated single channels under synaptic conditions. (A). Simulated single channel response to a 1 ms GABA pulse (1 mM), 
using the same model as in Figure 2. The Markov states corresponding to the conductance levels (1-3) are also shown on the right of the 
trace. (B). The number of openings recorded after the brief synaptic GABA pulse increased as affinity increased (by decreasing koff). (C). 
The frequency of openings was, however, unchanged across the same range of koff. Adapted from reference [5] with permission. Benzodiazepine Mechanism of Action  Current Neuropharmacology, 2010, Vol. 8, No. 1    15 
SINGLE-CHANNEL  OPENING  FREQUENCY  
DEPENDS ON MULTIPLE FACTORS 
  Although the term “mechanism” is sometimes used when 
describing changes in single-channel opening frequency due 
to a mutation or allosteric modulator, opening frequency is 
more  accurately  described  as  an  observation  because  it  is 
influenced  by  several  microscopic  mechanisms.  Observing 
changes in opening frequency does not uniquely map to  a 
specific kinetic mechanism, and the direction of change in 
frequency does not necessarily even correlate with efficacy 
in terms of total charge passed per time (that is, frequency 
and efficacy can be “uncoupled”). For example, consider a 
“flickering” open channel blocker, which could dramatically 
increase opening frequency despite being an antagonist that 
decreases the charge passed per time. Similarly, an agonist 
that  markedly  increased  open  duration  may  indirectly  de-
crease  opening  frequency,  despite  increasing  the  charge 
passed per time. Considering the above 4-state model, reduc-
ing the average occupancy of the D state (either by decreas-
ing the entry rate or increasing the exit rate) will increase 
opening  frequency,  as  well  as  gating  efficacy  (although  
deactivation will be faster). Increasing the D state occupancy 
will have the opposite impact. For increases in the open du-
ration (by decreasing kclose), the limit of opening frequency 
cannot be faster than the inverse of the mean open duration. 
One can imagine a case of prolonging open durations such 
that opening frequency decreases, yet  efficacy in  terms of 
charge passed per time increases. Note that the opening rate 
(kopen)  is  therefore  not  the  only  factor  determining  the  
observed opening frequency. In the case of BDZs, a single 
mechanism,  increased  affinity  via  decreasing  koff,  is  
predicted  to  have  different  functional  impacts  on  opening 
frequency,  depending  on  the  context  in  which  receptors  
are activated.  
EVIDENCE  THAT  BDZ  MODULATION  INVOLVES 
MORE THAN GABA AFFINITY 
  Studies  investigating  changes  in  reaction  rates  of  
engineered cysteine residues at or near those implicated in 
GABA  binding  demonstrated  movement  in  response  to 
BDZs [23], consistent with an affinity-based mechanism of 
enhancement.  However, certain experimental findings sug-
gest that BDZ modulation may also affect GABAA receptor 
gating. Chimeric γ-δ subunit analysis suggested that regions 
distant  from  the  putative  GABA  binding  pocket,  near  the 
first two transmembrane domains, as well as the TM2-TM3 
intracellular loop, were important for BDZ modulation [19]. 
Cysteine  modification  experiments  also  implicated  move-
ment in TM3 residues in response to BDZ (which did not 
appreciably activate the receptors in that study, suggesting 
these movements were not related exclusively to spontane-
ous gating) [56]. These reports suggest that BDZ modulation 
involves  structural  alterations  that  could  influence  channel 
gating.  
  In addition  to these structural  investigations, functional 
studies from several groups suggest  BDZ  modulation may 
influence channel gating. For example, Mercik et al. showed 
(in addition to a likely effect on GABA affinity), small ef-
fects  of  zolpidem  (but  not  flurazepam)  on  desensitization, 
and both zolpidem and flurazepam resulted in smaller maxi-
mal  GABA-evoked  currents  [35].  These  effects  have  not 
been seen with BDZs in other studies however [5, 28]. BDZs 
have been shown to enhance spontaneous GABAA receptor 
currents from mutated receptors by several groups [5, 6, 11, 
51]. In some cases, possibly requiring high receptor expres-
sion  levels,  spontaneous  currents  from  wild  type  α1β3γ2L 
receptors  (which  are  typically  very  small  compared  to 
GABA evoked currents) can be recorded and are enhanced 
by BDZs [1]. New generation BDZ binding site modulators 
also  enhance  spontaneous  currents,  as  zolpidem  increased 
the  spontaneous  activity  generated  by  the  α-subunit  pore 
mutation L263S [11]. Further support for effects on channel 
gating derived from the finding that diazepam increased the 
efficacy of GABAA receptor partial agonists; enhanced effi-
cacy of partial agonists using the  BDZ modulator chlordi-
azepoxide has been previously reported as well [32]. Rusch 
and Forman also demonstrated BDZ modulation of sponta-
neous  currents  resulting  from  α1(L264T)  mutation,  and 
showed that  efficacy of a partial GABAA receptor agonist 
was increased by the BDZ midazolam [48].  
  Simplified allosteric models (usually with one open state, 
one closed state, and no desensitization) have been proposed 
to  account  for  these  BDZ  modulation  results,  involving  a 
shift toward stabilizing the open/active conformation. How-
ever,  there  are  several  important  features  of  the  proposed 
Monod-Wyman-Changeux type models that are worth con-
sidering.  First,  they  typically  do  not  account  for  multiple 
open states, multiple closed states, or macroscopic desensiti-
zation.  Using  simplified  models  with  these  limitations  to 
generate concentration response curves without taking into 
account these features of GABAA receptor kinetics [48] is of 
uncertain utility, given the potential impact of these states (in 
particular,  the  desensitized  states).  Although  desensitized 
(and additional open) states could be included in these types 
of models, the connectivity and stability of D states can have 
non-intuitive effects on macroscopic current behavior even 
when cycles are not present [4]. Second, the multiple em-
bedded cycles that characterize these models makes mainte-
nance of detailed balance difficult, and failure to constrain 
microscopic  reversibility  [22]  implies  an  energy-requiring 
mechanism of uncertain source. Finally, this class of model 
involves binding cycles that explicitly allow GABA to bind 
and unbind from all states, including open states. In fact, the 
agonist efficacy in such models is directly related to the af-
finity differential between the open and resting states. How-
ever, such cycles are difficult to reconcile with data suggest-
ing that GABA does not unbind from (or, by inference, bind 
to) open or pre-open states [1], as described above. Although 
this finding is consistent with any non-cyclic model of the 
class exemplified by Fig. (1A), the cyclic models predict the 
opposite finding, which is that bicuculline should inhibit the 
deactivation  current  in  proportion  to  the  availability  un-
liganded open (or pre-open) receptors. If such receptor con-
formations  are  noncontributory  (unstable  once  GABA  un-
binds), then the MWC model appears to collapse to a non-
cyclic model. More complex linear models have been pro-
posed  for  αβγ  and  αβδ  isoforms,  which  generate  realistic 
current behavior under single channel, macroscopic, concen-
tration-response  curve,  and  allosteric  modulator  conditions 
[14, 17, 27].  16    Current Neuropharmacology, 2010, Vol. 8, No. 1  Matt T. Bianchi 
  The  finding  of  enhanced  spontaneous  currents  in  wild 
type and mutated channels appears difficult to reconcile with 
a BDZ mechanism that is strictly limited to GABA binding 
affinity, as pointed out by Rusch and Forman [48]. One po-
tential explanation for this apparent disparity is that sponta-
neous  gating  involves  distinct  conformations  compared  to 
liganded receptor gating. For example, consider a spontane-
ous transition from the state Cu in Fig. (1A) to an isolated 
open state, which can be accessed with low probability at 
baseline, and which can be favored by mutation or by the 
action  of  allosteric  modulators.  BDZs  could  influence  this 
transition, but in the presence of GABA the affinity mecha-
nism would dominate. Although it would not be surprising 
for careful study of any allosteric modulator to reveal effects 
on  multiple  kinetic  processes,  the  simulations  discussed 
above  nevertheless  point  to  distinct  predictions  of  altered 
affinity  (via  koff)  upon  GABAA  receptor  kinetics  under  
synaptic versus extrasynaptic conditions.  
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